T-PLL-1 protocol of the German CLL study group (GCLLSG) - a prospective phase II trial of fludarabine phosphate, mitoxantrone and cyclophosphamide (FMC) followed by alemtuzumab consolidation as first-line treatment in T-PLL.

Title:: T-PLL-1 protocol of the German CLL study group (GCLLSG) - a prospective phase II trial of fludarabine phosphate, mitoxantrone and cyclophosphamide (FMC) followed by alemtuzumab consolidation as first-line treatment in T-PLL.
Document type:: Meeting Abstract
Author(s):: Hopfinger, G; Kandler, G; Koller, E; Schmitt, B; Aul, C; Frickhofen, N; Grabenhorst, U; Herold, M; Jaeger, U; Marquart, F; Busch, R; Hallek, M
Journal title abbreviation:: Blood
Year:: 2003
Journal volume:: 102
Journal issue:: 11
Pages contribution:: 674A-674A
Language:: eng
Print-ISSN:: 0006-4971
TUM Institution:: Institut für Medizinische Statistik und Epidemiologie
BibTeX

Occurrences: